Ingevity Corporation (NYSE:NGVT – Get Free Report) CEO David Li sold 5,000 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the sale, the chief executive officer owned 120,636 shares of the company’s stock, valued at approximately $9,147,827.88. The trade was a 3.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ingevity Trading Down 2.4%
Shares of NYSE:NGVT traded down $1.78 during midday trading on Tuesday, reaching $74.01. The company’s stock had a trading volume of 177,777 shares, compared to its average volume of 291,037. The firm has a market capitalization of $2.54 billion, a price-to-earnings ratio of 50.34 and a beta of 1.16. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. The firm has a 50 day moving average price of $73.75 and a two-hundred day moving average price of $71.72. Ingevity Corporation has a fifty-two week low of $45.85 and a fifty-two week high of $79.29.
Ingevity (NYSE:NGVT – Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts forecast that Ingevity Corporation will post 5.4 earnings per share for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on NGVT
Hedge Funds Weigh In On Ingevity
Large investors have recently modified their holdings of the company. Global Retirement Partners LLC bought a new stake in Ingevity during the 4th quarter valued at $27,000. Frazier Financial Advisors LLC bought a new position in shares of Ingevity in the second quarter valued at $37,000. Meeder Asset Management Inc. acquired a new position in shares of Ingevity during the fourth quarter valued at about $33,000. Kestra Advisory Services LLC acquired a new position in shares of Ingevity during the fourth quarter valued at about $47,000. Finally, Geneos Wealth Management Inc. increased its position in shares of Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors.
About Ingevity
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Further Reading
- Five stocks we like better than Ingevity
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
